Case-Based Discussion: Early M1 CRPC Management and Advanced M1 CRPC
Presented by Kelly Stratton, MD and Alicia Morgans, MD This educational activity is supported by independent educational grants from: AbbVie Astellas AstraZeneca Bayer HealthCare Pharmaceuticals Inc...
18 Dec 202034min
Case-Based Discussion: BCR and mHSPC & M0 CRPC
Case-Based Discussion: BCR and mHSPC and M0 CRPC Presented by Stephen Boorjian, MD and Michael Cookson, MD This educational activity is supported by independent educational grants from: AbbVie Aste...
15 Dec 202045min
GU Podcast (2020): Genetic Testing And Personalized Medicine In Prostate Cancer
At the conclusion of this activity, participants will be able to: 1. Identify the role of genetic testing in men with advanced, metastatic and CRPC. 2. State the criteria for genetic testing of prosta...
9 Dec 202028min
GU Podcast (2020): Addressing Disparities in Prostate Cancer Care
At the conclusion of this activity, participants will be able to: 1. Examine racial and geographic disparities in in prostate cancer and prostate cancer care. 2. Identify important causes for disparit...
2 Dec 202032min
GU Podcast (2020): Chemo-ablation Of Upper-Tract Urothelial Carcinoma
At the conclusion of this activity, participants will be able to: 1. Identify new technologies for the treatment of urothelial carcinoma and analyze the risks and benefits of treatment. 2. Facilitate ...
25 Nov 202038min
GU Podcast (2020): Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline: Part 2
At the conclusion of this activity, participants will be able to: 1. Review the evidence and outcomes on the treatment of M1 HSPC, MO CRPC and M1 CRPC as outlined in the newly updated AUA Advanced, Me...
18 Nov 202023min
GU Podcast (2020): Targeted Therapies and Integration with Surgical Management of RCC
At the conclusion of this activity, participants will be able to: 1. Describe new and emerging targeted for patients with locally-advanced and advanced kidney cancer and the role of adjuvant therapy. ...
12 Nov 202029min
GU Podcast (2020): Immune Checkpoint Inhibitors In RCC
Immune Checkpoint Inhibitors in RCC At the conclusion of this activity, participants will be able to: 1. Discuss the current immunotherapy options available for the treatment of RCC. 2. Describe both ...
28 Okt 202031min
